Phage Therapy is Effective in Protecting Honeybee Larvae from American Foulbrood Disease

Sara Ghorbani-Nezami1, Lucy LeBlanc1, Diane G Yost1

  • 1Department of Biological Sciences, School of Life Sciences, University of Nevada Las Vegas, Las Vegas, NV 89154-4004.

Insights

Phage therapy shows promise in combating American foulbrood disease in honeybees. Treated larvae demonstrated high survival rates, suggesting a potential alternative to antibiotics for protecting Apis mellifera.

Area of Science:

  • Apiculture
  • Microbiology
  • Veterinary Entomology

Background:

  • American foulbrood disease, caused by Paenibacillus larvae, severely impacts honeybee (Apis mellifera) populations globally.
  • Bacterial endospores of P. larvae are highly durable and virulent, leading to rapid infections and often requiring destruction of infected hives.
  • Existing antibiotic treatments are becoming insufficient due to increasing resistance in P. larvae strains.

Purpose of the Study:

  • To evaluate the efficacy of bacteriophage therapy as a treatment and preventative measure against Paenibacillus larvae infection in honeybee larvae.
  • To assess the safety of phage therapy by determining any deleterious effects on honeybee larvae.

Main Methods:

  • Three Paenibacillus larvae phages (F, WA, XIII) were tested on artificially reared honeybee larvae infected with P. larvae spores.
  • Larval survival rates were compared between phage-treated groups and control groups (uninfected and spore-infected only).
  • Polymerase chain reaction (PCR) was used to confirm the presence of P. larvae DNA in dead larvae.

Main Results:

  • Phage treatment did not adversely affect honeybee larvae, with survival rates comparable to uninfected controls (84%).
  • Phage therapy significantly increased survival rates in infected larvae compared to spore-only treatment (45%).
  • Prophylactic phage administration (before infection) was more effective than post-infection treatment.

Conclusions:

  • Bacteriophage therapy is a safe and potentially effective strategy for managing American foulbrood disease in honeybees.
  • Further research is required to optimize phage combinations, concentrations, and test efficacy under field conditions.